AI news · OpenAI · life sciences
OpenAI buys Orchestra Bio to manage drug development work
The start-up’s AI agents track budgets and trial schedules for drugmakers, and its team joins Rosalind, OpenAI’s life sciences unit. Terms were not disclosed.
OpenAI said on Tuesday 20 October 2026 that it has bought Orchestra Bio, a San Francisco start-up founded in 2022. Orchestra makes AI agents, programs that take a goal and carry out the steps on their own, for drug companies. Neither side gave a price. The start-up had raised about $20 million, with Andreessen Horowitz and 8VC among its backers, TechCrunch reports.
The agents handle the logistics around a drug programme, from budgets to clinical trial schedules. Take a failed manufacturing batch: the agents trace the knock-on delays and draft options, and a person still picks one, Decrypt reports. OpenAI says a new medicine takes up to 15 years to reach US approval.
Rosalind, the biology unit OpenAI started in April, takes in Orchestra’s staff. Moderna and Novo Nordisk already use its tools, SiliconANGLE reports. OpenAI has not said when the agents reach customers. Anthropic made a similar move in April, paying about $400 million for Coefficient Bio.
With Orchestra, OpenAI’s Rosalind now covers the budgets and timetables of a drug programme as well as the science.
Sources
- TechCrunch: OpenAI acquires startup Orchestra Bio to beef up its biotech business. Checked
- Decrypt: OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work. Checked
- SiliconANGLE: OpenAI acquires Orchestra Bio to bring AI agents into drug development. Checked
More AI news from
- Anthropic’s leaked filing shows $16.3 billion in half-year sales
- SpaceX’s AI revenue jumps ninefold as Tesla merger talks begin
- Salesforce agrees to buy Braze for $5.66 billion in cash
- OpenAI says two of its coding agents weakened safety monitoring
- Gemini in your car can now read your Gmail and calendar
- Google open-sources TorchTPU to bring PyTorch apps to its chips
- Meta’s Muse passes 10 million US downloads in 40 days
- ASI, an AI firm for air traffic and grids, raises $325 million
- DeepSeek open-sources the engine behind its own AI service